196 results
8-K
PRPO
Precipio Inc
13 Dec 13
Other Events
12:00am
”), which offers its Blue Plans affiliates access to competitive pricing for Transgenomic’s valuable molecular diagnostic tests and services … access to Transgenomic’s portfolio of medically important genetic tests. The tests provide treating physicians with actionable information that helps
8-K
EX-99.1
PRPO
Precipio Inc
20 Jul 22
Agreement Enhances Precipio’s Product Reach to US Laboratories
7:16pm
access to laboratories across the United States for Precipio’s HemeScreen suite of products. This partnership is a logical expansion of Precipio’s … with the Fisher Healthcare channel will expand access to customers and drive distribution and revenue for our HemeScreen product suite”, said Keith Meadors
8-K
EX-99.1
PRPO
Precipio Inc
13 Mar 13
Transgenomic Reports Fourth Quarter and Fiscal Year 2012 Financial Results
12:00am
, an established revenue and customer base, and access to a testing market estimated at more than 400,000 patients in the United States alone.
Medicare … , the 48 million Americans currently covered by Medicare will have access to this important genetic test.
ICE COLD-PCR Collaborations:In addition to our
8-K
EX-99.1
PRPO
Precipio Inc
25 Feb 22
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022
6:51pm
with the challenge of access to physician offices and patients deferring non-emergency office visits related to COVID protocols. The main increase in revenue growth … technical team thus translating into a longer onboarding time period. As a result of limited access at our customer’s labs due to COVID restrictions
8-K
EX-99.1
ai9t8wn5
20 Nov 03
Other events
12:00am
DEFA14A
lhxw7
29 Apr 20
Additional proxy soliciting materials
4:34pm
8-K
EX-99.1
tdf4 xd6gqjpp
10 Mar 11
Transgenomic Reports Fourth Quarter Financial Results
12:00am
8-K
EX-99.1
0e4me178x1gstypep
12 Mar 14
Transgenomic Reports Fourth Quarter and Fiscal Year 2013 Financial Results
12:00am
8-K
EX-99.1
2jm9g0ybtn2udxh64o
12 May 11
Transgenomic Reports First Quarter Financial Results
12:00am
8-K
EX-99.1
tojgdu2knu4
11 Aug 11
Transgenomic Reports Second Quarter Financial Results
12:00am
S-1
EX-10.5
e3871j
10 Mar 00
IPO registration
12:00am
8-K
EX-99.1
t3sgxqj
4 Jan 11
Transgenomic Announces Closing of the Acquisition of Clinical Data’s Diagnostic Business and the Closing of a $6 Million Financing
12:00am
8-K
EX-99.1
an8h2yo5ai5onw2v8
2 Jul 14
Selective Monetization of Research Market Assets Reflects Strategic Focus on Higher Growth olecular Diagnostics and Personalized Medicine Sectors
12:00am
8-K
EX-99.1
no7760g0 tu4l4czc
3 Dec 03
Other events
12:00am
8-K
EX-99.1
gr57a82qj 08kqspi
18 Feb 20
Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership
4:00pm